What conversations are going on in healthcare boardrooms right now? How will the COVID-19 crisis impact healthcare dealmaking? What sectors will private equity investors and strategic buyers continue to target? What will they avoid? How will key healthcare stakeholders re-evaluate their M&A strategies? Join us on Friday, May 15th, 2020 for an exclusive video panel discussion with highly regarded healthcare dealmakers for real-time, in-depth perspectives.
Before we hear from healthcare executives on the front lines of M&A and investing, we’ll hear from Andreas Dirnagl, MUFG’s Head of Global Healthcare Research, for an update on the economic impact of COVID-19 across the healthcare ecosystem.
Date: Friday, May 15, 2020
Time: 10 a.m. PST / 1 p.m. EST
Duration: 1 hour
To Register, please click here.
Opening Remarks & Moderators
 |  |
| Adam Abramowitz Managing Director, Intrepid | Jonathan Bluth Director, Intrepid |
Healthcare Market Observations
 |
Andreas J. Dirnagl |
Panelists
 |  |
Jeff Bailet, MD | Jamey Edwards |
 |  |
| Mehran Ahmed Principal, Webster Equity | Beth Everett Managing Director, MUFG Healthcare |